Brain aromatase expression after experimental stroke: topography and time course.

J Steroid Biochem Mol Biol

Wellcome Surgical Institute, Division of Clinical Neuroscience, University of Glasgow, Glasgow G61 1QH, Scotland, UK.

Published: June 2005

Brain aromatase has been shown to be increased in expression after neurotoxic damage and to exert neuroprotection via generation of local oestrogens. The present study investigates the topography and time course of brain aromatase expression after experimental stroke (middle cerebral artery occlusion (MCAO)). Ovariectomised stroke prone spontaneously hypertensive rats underwent distal MCAO by electrocoagulation. Immunohistochemistry revealed increased brain aromatase expression at 24h and 8 days in the cortical penumbra/peri-infarct zones with no increase evident at 2h or 30 days post-MCAO. Double label studies indicate that some of the increased aromatase expression is associated with astrocytic processes. Thus, this is the first evidence that aromatase protein is increased after MCAO and the location (peri-infarct), time course (within 24h) and cellular localisation (astrocytic) indicate the potential for aromatase to promote the survival of cells in the penumbra after experimental stroke by local synthesis of oestrogens.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2005.02.016DOI Listing

Publication Analysis

Top Keywords

brain aromatase
16
aromatase expression
16
experimental stroke
12
time course
12
expression experimental
8
topography time
8
course brain
8
aromatase
6
expression
5
brain
4

Similar Publications

Aromatase plays a crucial role in the conversion of androgens to oestrogens and is often overexpressed in hormone-dependent tumours, particularly breast cancer. [18F]BIBD-071, which has excellent binding affinity for aromatase and good pharmacokinetics, has potential for the diagnosis and treatment of aromatase-related diseases. The MCF-7 cell line, which is hormone receptor-positive (HR+), was used in the assessment of the novel [18F]-labelled radiotracer [18F]BIBD-071 via positron emission tomography (PET) imaging of an HR+ breast cancer xenograft model.

View Article and Find Full Text PDF

The ultrastructural organization of the nuclei of the tegmental region in juvenile chum salmon () was examined using transmission electron microscopy (TEM). The dorsal tegmental nuclei (DTN), the nucleus of (NFLM), and the nucleus of the oculomotor nerve (NIII) were studied. The ultrastructural examination provided detailed ultrastructural characteristics of neurons forming the tegmental nuclei and showed neuro-glial relationships in them.

View Article and Find Full Text PDF

Sexual and Metabolic Differences in Hippocampal Evolution: Alzheimer's Disease Implications.

Life (Basel)

November 2024

Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, Faculty of Health Sciences, University of Jaen, Las Lagunillas University Campus, 23009 Jaen, Spain.

Sex differences in brain metabolism and their relationship to neurodegenerative diseases like Alzheimer's are an important emerging topic in neuroscience. Intrinsic anatomic and metabolic differences related to male and female physiology have been described, underscoring the importance of considering biological sex in studying brain metabolism and associated pathologies. The hippocampus is a key structure exhibiting sex differences in volume and connectivity.

View Article and Find Full Text PDF
Article Synopsis
  • Enrofloxacin (ENR) affects steroid metabolism in female crucian carp by increasing testosterone synthesis and inhibiting its conversion to estradiol.
  • The study evaluated the impact of ENR on the levels of testosterone and estradiol in blood and brain, as well as the expression of key genes involved in hormone regulation.
  • Findings showed that ENR activates certain genes (scg2a and gth 2β) while repressing aromatase B (cyp19a1b), with the PI3K/Akt signaling pathway being involved in these hormonal changes.
View Article and Find Full Text PDF

Background: Optimal therapy following breast-conserving surgery in older adults with low-risk, early-stage breast cancer remains uncertain. The EUROPA trial aims to compare the effects of radiotherapy and endocrine therapy as single-modality treatments on health-related quality of life (HRQOL) and ipsilateral breast tumour recurrence (IBTR) outcomes in this population.

Methods: This non-inferiority, phase 3, randomised study was conducted at 18 academic hospitals across Italy (17 centres) and Slovenia (one centre).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!